Stream Biomedical, Inc.
Stream Biomedical, Inc. is a clinical-stage biopharmaceutical company focused on developing first-in-class targeted therapeutics for acute neurotrauma and chronic neurodegenerative diseases. The company is dedicated to revolutionizing cerebrovascular repair and developing novel solutions for neurotrauma and neurodegeneration, including conditions such as stroke, traumatic brain injury, and Alzheimer's disease.
Industries
N/A
Nr. of Employees
small (1-50)
Stream Biomedical, Inc.
2450 Holcombe Boulevard, Suite J Houston, TX 77021
Products
Recombinant perlecan domain V (DV) and LG3 subdomain therapeutic candidates
Preclinical therapeutic candidates based on perlecan domain V and its LG3 subdomain evaluated for neuroprotective and angiogenic-restorative effects in models of ischemic stroke and neurodegeneration.
Recombinant perlecan domain V (DV) and LG3 subdomain therapeutic candidates
Preclinical therapeutic candidates based on perlecan domain V and its LG3 subdomain evaluated for neuroprotective and angiogenic-restorative effects in models of ischemic stroke and neurodegeneration.
Services
Presentation of preclinical data via posters and slide decks at scientific meetings.
Presentation of preclinical data via posters and slide decks at scientific meetings.
Expertise Areas
- Therapeutic development for neurotrauma
- Therapeutic development for neurodegenerative disease
- Preclinical stroke models and neurovascular assessment
- Recombinant protein therapeutic design
Key Technologies
- Recombinant protein expression and purification
- Rodent ischemic stroke models
- 3D neurovascular imaging
- Endothelial cell toxicity and angiogenesis assays
News & Updates
Stream Biomedical, Inc. participated in the American Society for Experimental Neurotherapeutics (ASENT) Annual Meeting on March 13th, 2025.
Stream Biomedical, Inc. participated in the American Society for Experimental Neurotherapeutics (ASENT) Annual Meeting on March 13th, 2025.